Expression of insulin-like growth factor I messenger ribonucleic acid in regenerating bone after fracture: influence of indomethacin

J Bone Miner Res. 1992 Feb;7(2):207-13. doi: 10.1002/jbmr.5650070212.

Abstract

Expression of insulin-like growth factor I (IGF-I) was studied during time in the callus formed after tibial fracture in rats. Levels of IGF-I mRNA in callus peaked on the day 8 postfracture, showing a 10- to 15-fold induction compared to control bone. Levels of IGF-I mRNA tended also to be increased in the fracture-adjacent musculus tibialis anterior. IGF-I immunoreactivity was found in cartilaginous cells, osteoblasts, and myocytes 6 and 8 days after fracture. No obvious differences were found between hypophysectomized animals and control animals with regard to IGF-I immunoreactivity. Administration of the antiinflammatory drug indomethacin decreased the IGF-I mRNA expression in the tibial fracture model. Previous findings have shown that IGF-I is activated during in vivo muscle regeneration, and also in this model indomethacin administration reduces the expression of IGF-I. The finding that indomethacin administration reduces IGF-I expression could indicate that an inflammatory response may be important for activation of IGF-I during tissue regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Regeneration / drug effects*
  • Bony Callus / metabolism
  • Immunohistochemistry
  • Indomethacin / therapeutic use*
  • Insulin-Like Growth Factor I / genetics*
  • Male
  • Nucleic Acid Hybridization
  • RNA, Messenger / biosynthesis*
  • Rats
  • Rats, Inbred Strains
  • Tibial Fractures / drug therapy*

Substances

  • RNA, Messenger
  • Insulin-Like Growth Factor I
  • Indomethacin